FarmaMondo Partners with Cordex to Expand Zemcelpro
LUGANO, Switzerland & MONTREAL, Canada, July 16, 2026 FarmaMondo Group has entered an exclusive commercial partnership with Cordex Biologics...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
LUGANO, Switzerland & MONTREAL, Canada, July 16, 2026 FarmaMondo Group has entered an exclusive commercial partnership with Cordex Biologics...
MELBOURNE, Australia, July 17, 2026 Dimerix Limited has secured an initial AU$10 million non-dilutive loan facility to strengthen its...
SAN FRANCISCO, Calif., June 26, 2026 Siren Biotechnology has been awarded an $8 million non-dilutive CLIN2 grant from the...
SAN FRANCISCO and BOSTON, May 27, 2026 Apogee Therapeutics announced a landmark $1.3 billion strategic financing collaboration with Blackstone...
